This story was updated after the deal closed. Carvana is tapping the Dallas-Fort Worth car market in a quest to deepen inroads into brick-and-mortar auto retail. The online used car giant is ...

SHANGHAI, Sept 23 (Reuters) - Innovent Biologics' (1801.HK), opens new tab newly launched weight-loss drug is making inroads in its home market of China, ramping up competition with its Western rivals ...

The drug boat destroyed by a U.S. air strike announced on Friday by President Donald Trump was carrying about 1,000 kilograms, or about 2,200 pounds, of suspected cocaine, Dominican Republic officials ...

CELEBRITIES BORN ON THIS DAY: Tom Felton, 38; Bonnie Hunt, 64; Andrea Bocelli, 67; Joan Jett, 67. Happy Birthday: Take a new approach to life, love and achieving the happiness you deserve. A change of ...

The Department of Agriculture announced it will stop publishing reports on food security in the United States, which the agency said have consistently been rife with “liberal fodder.” In a press ...

WORCESTER — An unwelcome visitor is underfoot at the Worcester Common. Literally. The remnants of squashed spotted lanternflies, an invasive insect species, litter the downtown streets. "You walk a ...

American Express unveiled long-awaited upgrades to its US Platinum cards on Thursday, adding new perks worth over $3,500 annually while raising the annual fee by $200. The card refresh reflects a ...

Roche targets liver disease treatments with acquisition Deal includes $14.50 a share, potential milestone payments up to $6.00 a share Roche flags potential to treat obesity-related conditions The ...

To make the world smarter, happier, and richer. Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches ...

Broadcom has a massive opportunity in custom chips. Inference should be a growth driver for AMD. TSMC is a winner regardless of which chip companies take market share. Let's look at three AI stocks ...

FRANKFURT (Reuters) - Roche has agreed to buy U.S. biotech firm 89bio for up to $3.5 billion, joining a race to offer new liver disease treatments that complement an intense push in the area of weight ...